Last Price$155.4(2.4%)
Market Cap$8,979.7M
(8.0%)
Industry median - 3.3%
5Y Historical average - 27.4%
N/A
Industry median - 9.2%
5Y Historical average - 37.0%
N/A
Industry median - 9.0%
5Y Historical average - 52.6%
34.7%
Industry median - 4.2%
5Y Historical average - 59.4%
RGEN Growth Rating
RGEN Growth rating
7.2
RGEN Growth rating performance
RGEN Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with RGEN Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$8,979.7M | 7.2 | 19.5% | (8.0%) | 0.3% | N/A | N/A | 140.7% | 31.3% | 34.7% | |
$207.3B | 7.7 | 13.3% | 17.2% | 14.2% | 16.2% | 65.6% | 20.5% | (1.7%) | 43.7% | |
$66.3B | 5.9 | 3.5% | 5.9% | 9.0% | 17.0% | 41.9% | 145.1% | 0.7% | 10.9% | |
$46.6B | 5.8 | 5.7% | 3.6% | 2.8% | N/A | (26.4%) | 50.8% | 20.0% | 14.4% | |
$34.6B | 7.5 | 12.1% | 12.9% | 9.2% | 4.9% | (33.4%) | 35.4% | 27.0% | 47.1% | |
$18.6B | 5.4 | 8.0% | 8.4% | 5.8% | (26.9%) | 32.2% | 102.2% | (7.3%) | 34.0% | |
$17.9B | 4.1 | 2.5% | (14.0%) | 148.7% | N/A | 188.4% | N/A | (16.7%) | (45.3%) | |
$16.9B | 5.0 | 9.5% | (1.9%) | 5.3% | 15.6% | (15.6%) | 10.7% | 2.8% | (33.3%) | |
$14.7B | 7.6 | 3.6% | 1.8% | 3.4% | 27.9% | 50.0% | 27.1% | 16.2% | 32.2% | |
$10.4B | 6.0 | 17.4% | 2.3% | 1.9% | N/A | N/A | 161.9% | (0.5%) | 2,170.3% | |
$9,757.8M | 6.7 | 4.6% | 2.7% | 5.0% | 8.2% | 30.2% | 4.4% | 5.5% | 36.0% |
FAQ
What is the Repligen Corporation (RGEN) revenue growth?
The Repligen Corporation (RGEN) revenue growth is (8.0%), which is lower than the industry median of 3.3% and the 5-year historical average of 27.4%.
What is the Repligen Corporation (RGEN) operating income growth?
The Repligen Corporation (RGEN) operating income growth is N/A, compared to the industry median of 9.2% and the 5-year historical average of 37.0%.
What is the Repligen Corporation (RGEN) EPS (Earnings Per Share) growth?
The Repligen Corporation (RGEN) EPS growth is N/A, compared to the industry median of 9.0% and the 5-year historical average of 52.6%.
What is the Repligen Corporation (RGEN) Free Cash Flow (FCF) growth?
The Repligen Corporation (RGEN) Free Cash Flow growth is 34.7%, compared to the industry median of 4.2% and the 5-year historical average of 59.4%.